Search Results - "Veritti, D"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Dexamethasone implant in diabetic macular edema in real-life situations by Chhablani, J, Bansal, P, Veritti, D, Sambhana, S, Sarao, V, Pichi, F, Carrai, P, Massaro, D, Lembo, A, Mansour, A M, Banker, A, Gupta, S R, Hamam, R, Lanzetta, P

    Published in Eye (London) (01-03-2016)
    “…Purpose To report outcome of eyes with recalcitrant and naive eyes with diabetic macular edema (DME) treated with intravitreal dexamethasone implants (Ozurdex)…”
    Get full text
    Journal Article
  2. 2

    Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study by Lanzetta, P, Furlan, F, Morgante, L, Veritti, D, Bandello, F

    Published in European journal of ophthalmology (01-11-2008)
    “…To verify the efficacy of nonvisible micropulse diode laser irradiation in the treatment of central serous chorioretinopathy (CSC). Twenty-two patients with…”
    Get full text
    Journal Article
  3. 3

    Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options by Veritti, Daniele, Sarao, Valentina, Soppelsa, Valentina, Lanzetta, Paolo

    Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2021)
    “…This meta-analysis aims to summarize 12-month best-corrected visual acuity (BCVA) outcomes in response to anti-vascular endothelial growth factor (VEGF)…”
    Get full text
    Journal Article
  4. 4

    Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review by Lanzetta, Paolo, Mitchell, Paul, Wolf, Sebastian, Veritti, Daniele

    Published in British journal of ophthalmology (01-12-2013)
    “…Antivascular endothelial growth factor (anti-VEGF) therapy has revolutionised the treatment of wet age-related macular degeneration (wAMD). Recent research has…”
    Get more information
    Journal Article
  5. 5

    Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors by Veritti, Daniele, Sarao, Valentina, Lanzetta, Paolo

    “…To evaluate the safety and efficacy of a combined approach using an antivascular endothelial growth factor (VEGF) agent (bevacizumab) and a steroid…”
    Get more information
    Journal Article
  6. 6

    A case of CRB1 -negative Coats-like retinitis pigmentosa by Sarao, Valentina, MD, Veritti, Daniele, MD, Prosperi, Raffaele, CO, Pignatto, Silvia, MD, Lanzetta, Paolo, MD

    Published in Journal of AAPOS (01-08-2013)
    “…Retinitis pigmentosa is a heterogeneous group of ocular diseases that causes progressive degeneration of the photoreceptor cells mainly affecting the rods of…”
    Get full text
    Journal Article
  7. 7